These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20959280)

  • 1. Long-term remission of primary erythermalgia with R1150W polymorphism in SCN9A after chemical lumbar sympathectomy.
    Zhang L; Wang WH; Li LF; Dong GX; Zhao J; Luan JY; Sun TT
    Eur J Dermatol; 2010; 20(6):763-7. PubMed ID: 20959280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical lumbar sympathectomy in the treatment of recalcitrant erythromelalgia.
    Wang WH; Zhang L; Dong GX; Sun TT; Lin ZM; Yang Y; Li X
    J Vasc Surg; 2018 Dec; 68(6):1897-1905. PubMed ID: 30126782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
    Natkunarajah J; Atherton D; Elmslie F; Mansour S; Mortimer P
    Clin Exp Dermatol; 2009 Dec; 34(8):e640-2. PubMed ID: 19549232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off.
    Choi JS; Zhang L; Dib-Hajj SD; Han C; Tyrrell L; Lin Z; Wang X; Yang Y; Waxman SG
    Exp Neurol; 2009 Apr; 216(2):383-9. PubMed ID: 19162012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia.
    Burns TM; Te Morsche RH; Jansen JB; Drenth JP
    Br J Dermatol; 2005 Jul; 153(1):174-7. PubMed ID: 16029345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation.
    Skeik N; Rooke TW; Davis MD; Davis DM; Kalsi H; Kurth I; Richardson RC
    Vasc Med; 2012 Feb; 17(1):44-9. PubMed ID: 22033523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.
    Drenth JP; te Morsche RH; Guillet G; Taieb A; Kirby RL; Jansen JB
    J Invest Dermatol; 2005 Jun; 124(6):1333-8. PubMed ID: 15955112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; primary erythermalgia--a neuropathic disease as a consequence of mutations in a sodium pump gene].
    Drenth JP; te Morsche RH; Michiels JJ
    Ned Tijdschr Geneeskd; 2006 Jan; 150(4):194-6. PubMed ID: 16471234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of primary erythermalgia, wintry hypothermia and encephalopathy.
    Takahashi K; Saitoh M; Hoshino H; Mimaki M; Yokoyama Y; Takamizawa M; Mizuguchi M; Lin ZM; Yang Y; Igarashi T
    Neuropediatrics; 2007 Jun; 38(3):157-9. PubMed ID: 17985268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation hotspots of SCN9A in primary erythermalgia.
    Zhang LL; Lin ZM; Ma ZH; Xu Z; Yang YL; Yang Y
    Br J Dermatol; 2007 Apr; 156(4):767-9. PubMed ID: 17263810
    [No Abstract]   [Full Text] [Related]  

  • 11. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.
    Michiels JJ; te Morsche RH; Jansen JB; Drenth JP
    Arch Neurol; 2005 Oct; 62(10):1587-90. PubMed ID: 16216943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A.
    Drenth JP; Te Morsche RH; Mansour S; Mortimer PS
    Arch Dermatol; 2008 Mar; 144(3):320-4. PubMed ID: 18347287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of familial erythermalgia with the association of lidocaine and mexiletine].
    Legroux-Crespel E; Sassolas B; Guillet G; Kupfer I; Dupre D; Misery L
    Ann Dermatol Venereol; 2003 Apr; 130(4):429-33. PubMed ID: 12843854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
    Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E
    Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.
    Yang Y; Wang Y; Li S; Xu Z; Li H; Ma L; Fan J; Bu D; Liu B; Fan Z; Wu G; Jin J; Ding B; Zhu X; Shen Y
    J Med Genet; 2004 Mar; 41(3):171-4. PubMed ID: 14985375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
    Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
    Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7.
    Han C; Rush AM; Dib-Hajj SD; Li S; Xu Z; Wang Y; Tyrrell L; Wang X; Yang Y; Waxman SG
    Ann Neurol; 2006 Mar; 59(3):553-8. PubMed ID: 16392115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analgesic effects of chemical lumbar sympathectomy on refractory pain in the lower limbs].
    Yang HJ; Peng KR; Hu SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):1968-70. PubMed ID: 19033104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of primary erythromelalgia (erythermalgia) treated with neural blockade].
    Takeda S; Tomaru T; Higuchi M
    Masui; 1989 Mar; 38(3):388-93. PubMed ID: 2661881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcome of percutaneous computed tomography-guided chemical lumbar sympathectomy for patients with causalgia after lumbar discectomy.
    Lee KS; Su YF; Lieu AS; Chuang CL; Hwang SL; Howng SL; Lin CL
    Surg Neurol; 2008 Mar; 69(3):274-9; discussion 279-80. PubMed ID: 17825373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.